DEMENTIA MODERATE
Clinical trials for DEMENTIA MODERATE explained in plain language.
Never miss a new study
Get alerted when new DEMENTIA MODERATE trials appear
Sign up with your email to follow new studies for DEMENTIA MODERATE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can daily light and sound slow Alzheimer's? major trial seeks answers
Disease control OngoingThis study is testing whether a daily treatment using special light and sound stimulation can slow the progression of Alzheimer's disease. About 670 people with mild to moderate Alzheimer's will use either the active stimulation device or a look-alike sham device at home for a ye…
Matched conditions: DEMENTIA MODERATE
Phase: NA • Sponsor: Cognito Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New Alzheimer's pill aims to slow mental decline in major trial
Disease control OngoingThis clinical trial is testing whether a daily pill called Xanamem can help control symptoms in people with mild to moderate Alzheimer's disease dementia. The study involves 247 participants who will take either the medication or a placebo for 36 weeks, followed by an optional ex…
Matched conditions: DEMENTIA MODERATE
Phase: PHASE2, PHASE3 • Sponsor: Actinogen Medical • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC